Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK’s Votrient gains new licence

August 8, 2012
Sales and Marketing GSK, NICE, Votrient, soft cell sarcoma

GlaxoSmithKline has gained a new European licence for its cancer pill Votrient adding to its renal cell carcinoma licence. The …

News

Regeneron to expand workforce at New York facility

August 8, 2012
Manufacturing and Production Arcalyst, Eylea, Regeneron, Zaltrap

Buoyant product sales at US biotech Regeneron have prompted the company to undertake a recruitment drive at its manufacturing facility …

News
Champix image

Champix better than patches for smoking cessation

August 7, 2012
Sales and Marketing Champix, FDA, Pfizer, Zyban, smoking

New research shows that Pfizer’s Champix is better than nicotine patch therapy at helping smokers kick the habit. A Pfizer …

News

Ticking all the Boxes

August 7, 2012
Manufacturing and Production

Pharmaceutical packaging has many functions to perform but in the OTC area of the market brand owners and product manufactures …

Feature
Thought Leadership
GE Healthcare image

GE and iBio expand plant production alliance

August 7, 2012
Manufacturing and Production GE Healthcare, iBio, iBioLaunch

GE Healthcare and iBio have forged an alliance to commercialise plant-based technologies for the manufacture of biologic drugs and vaccines. …

News

Boehringer wins contract to make Servier’s gevokizumab

August 7, 2012
Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody

Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …

News
AZ app image

AstraZeneca launches prostate cancer app

August 7, 2012
Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …

News
richard-vellacott

Horizon Discovery appoints chief financial officer

August 7, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Horizon Discovery, Richard Vellacott

Horizon Discovery has announced the appointment of Richard Vellacott as chief financial officer. The firm which is a provider of …

Appointment

What Does E-Detailing Entail? How E-Detailing is Shaping the Pharmaceutical Industry

August 7, 2012
Sales and Marketing e-detailing, sales, sales reps

E-detailing has come at a time of great change in the pharmaceutical industry. The economic recession hit hard with pressure …

Feature
Thought Leadership
Pfizer image

Pfizer/Janssen Alzheimer’s drug dropped after failure

August 7, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …

News

Opposition mounting to EU’s API import regulations

August 7, 2012
Manufacturing and Production API, EU, TBT, WTO, manufacturing

Changes to the EU’s rules governing the importation of active pharmaceutical ingredients (APIs) are being opposed by the governments of …

News
merck_incweb

Merck’s Singulair faces generic rivals

August 7, 2012
Sales and Marketing Merck, Singulair, generic erosion, patent

Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …

News
ABPI image

Whitehead to GPs: don’t squeeze the drugs budget

August 7, 2012
Medical Communications, Sales and Marketing ABPI, CCGs, GPs, NHS, PCTs, reform

GPs should value the drug industry and not seek to squeeze the drugs bill as their predecessors have done, says …

News
Rawlins image

Sue NHS to ensure access to drugs, says NICE chief

August 6, 2012
Lucentis, NICE, Ozurdex, judicial review, market access, ophthamology

 The chairman of NICE is advising campaigners to sue NHS bodies that block a treatment recommended by the watchdog.In a …

News

Novartis and Pennsylvania team up on cancer research

August 6, 2012
Research and Development Cancer, Novartis, University of Pennsylvania, chimeric antigen receptor

Novartis and the University of Pennsylvania have joined forces to investigate a method of treating cancer which encourages patients’ immune …

News

Sanofi’s colorectal cancer drug gains FDA approval

August 6, 2012
Sales and Marketing FDA, Sanofi, Zaltrap, colorectal cancer

The FDA has approved Sanofi and Regeneron’s new oncology drug Zaltrap for aggressive forms of colorectal cancer.Zaltrap (ziv-aflibercept), in combination …

News
ian_broadway

Talentmark appoints director of Managed Services

August 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ian Broadway, Talentmark

Life sciences recruitment firm Talentmark has appointed Ian Broadway as director of Managed Services. Broadway is an experienced life science …

Appointment
ABPI image

ABPI outlines vision for drug pricing reform

August 3, 2012
Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing

The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …

News
GSK image

GSK submits melanoma drugs for regulatory approval

August 3, 2012
Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology

GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …

News

Government healthcare fund pays up

August 3, 2012
Research and Development, Sales and Marketing ABPI, MRC, SMEs, government

A £180 million government fund to help small businesses and academics come up with healthcare solutions has made its first …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026